Article

Prioritize Solvent Recycling And Recovery To Realize Your Green Goals

Source: Lonza

By Niklaus Künzle, Senior Director and Head of Global Process Technology and Innovation for Small Molecules, and Brian Schwegler, Associate Director for Thermal Separations and Sustainability from the Process Technology and Innovation Group

GettyImages-1346739457-environmental-sustainability-pill-tablet-capsule-OSD-green

As sustainability becomes a leading initiative across the pharmaceutical industry, sponsors are looking for manufacturing partners that can develop their products efficiently while minimizing their ecological footprint. It is a delicate and, at times, difficult balance to strike. At Lonza, we prioritize being open with customers and colleagues about how we are building sustainability into the DNA of our business, because it takes a collaborative effort to combat the effects of climate change. As part of our Vision ZERO initiative, we are taking concrete steps to realize our goals of reducing emissions, raw material consumption, and waste.

As a contract development and manufacturing organization (CDMO), we are committed to supporting our customers as they deliver innovative therapies to enable a healthier world. Contributing to a healthier world also entails reducing our ecological footprint. A major part of this effort is solvent recovery and recycling, which stands to have a huge impact on carbon emission reduction efforts. Download the full article to explore how our strategies and technologies for solvent recovery yielded significant CO2 reductions in 2022.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.

Subscribe to Drug Discovery Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Drug Discovery Online